NAV12/1/2016 Chg.-6.6200 Type of yield Investment Focus Investment company
377.7500USD -1.72% reinvestment Equity Worldwide Bellevue Asset Mgmt. 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2009 - - - 2.88 4.05 5.17 7.56 0.15 5.07 -10.89 6.76 0.37 -
2010 1.37 2.88 4.90 -1.65 -12.38 -3.44 3.02 -2.03 12.01 6.40 -4.72 7.46 +12.10%
2011 -2.91 0.16 0.92 8.13 0.01 -0.79 -2.10 -13.30 -7.02 5.96 0.39 2.95 -9.00%
2012 13.39 1.68 3.30 0.35 -0.58 3.74 3.80 1.95 5.67 -8.59 4.96 -0.58 +31.48%
2013 7.49 1.65 7.76 9.32 2.92 -3.92 14.70 -2.77 9.09 -3.21 8.20 0.98 +63.75%
2014 9.96 6.60 -10.90 -4.05 2.82 8.50 -1.15 11.32 -1.20 10.11 2.59 -0.70 +36.33%
2015 7.89 5.71 0.50 -3.89 9.81 -0.41 2.01 -11.59 -12.36 9.46 2.34 0.90 +7.63%
2016 -23.11 -5.21 4.49 3.99 3.33 -9.40 13.18 -2.83 2.91 -14.05 8.71 -1.72 -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 31.40% 28.47% 31.22% 28.54% 25.26%
Sharpe ratio -0.78 -0.41 -0.71 0.16 0.81
Best month +13.18% +13.18% +13.18% +13.18% +14.70%
Worst month -23.11% -14.05% -23.11% -23.11% -23.11%
Maximum loss -30.86% -20.50% -31.76% -42.26% -42.26%
Outperformance -13.06% - -14.14% -1.21% +58.44%
 
All quotes in USD

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
BB Adamant Biotech I USD reinvestment 399.9000 -21.93% +16.15%
BB Adamant Biotech I EUR reinvestment 504.7400 -21.96% +48.39%
BB Adamant Biotech I CHF reinvestment 357.2500 -23.10% +29.74%
BB Adamant Biotech B USD reinvestment 377.7500 -22.51% +13.59%
BB Adamant Biotech B CHF reinvestment 335.6400 -23.67% +26.89%
BB Adamant Biotech B EUR reinvestment 475.0100 -22.54% +45.12%

Performance

YTD
  -22.94%
6 Months
  -6.15%
1 Year
  -22.51%
3 Years  
+13.59%
5 Years  
+149.29%
Since start  
+202.20%
Year
2015  
+7.63%
2014  
+36.33%
2013  
+63.75%
2012  
+31.48%
2011
  -9.00%
2010  
+12.10%